DexCom earnings beat by $0.03, revenue topped estimates
In a recent transaction filed with the Securities and Exchange Commission, Luke A. Sarsfield III, Chairman and CEO of P10, Inc. (NYSE:PX), purchased 5,000 shares of the company’s Class A Common Stock. The acquisition, dated June 9, 2025, was executed at a price of $9.87 per share, amounting to a total transaction value of $49,349. This insider purchase comes as the stock has declined about 25% over the past six months, according to InvestingPro data.
Following this purchase, Sarsfield’s direct ownership in P10, Inc. increased to 188,134 shares. The transaction highlights the executive’s continued confidence in the company’s prospects. InvestingPro analysis suggests the stock is currently undervalued, with analyst price targets ranging from $13 to $20 per share. Subscribers to InvestingPro can access the comprehensive Pro Research Report for P10, which is one of 1,400+ US stocks covered with detailed analysis and actionable insights.
In other recent news, P10 Inc reported its first quarter 2025 earnings, revealing an earnings per share (EPS) of $0.04, which was significantly below the forecasted $0.21. The company’s revenue also fell short, coming in at $67.7 million compared to the expected $70.1 million. Despite these shortfalls, P10 experienced a 2% year-over-year increase in revenue and a 10% growth in fee-paying assets under management, reaching $26.3 billion. The company’s adjusted net income decreased by 8% to $23.5 million, while fully diluted ANI EPS fell by 5% year-over-year.
JPMorgan analyst Kenneth Worthington revised the price target for P10 to $14.50, down from $15.00, but maintained an Overweight rating on the company’s shares. The analyst noted that P10’s first quarter adjusted net income per share of $0.20 met JPMorgan’s estimates but fell short of the Bloomberg consensus of $0.21. Despite these challenges, Worthington highlighted positive developments at P10, such as increased transparency, product expansion, and strategic mergers and acquisitions.
The acquisition of European solutions provider Qualitas was particularly noted as a strategic move, adding $1 billion in fee-paying assets under management. P10’s management maintained its full-year guidance, citing seasonality and timing as reasons for the first-quarter deviations. The company also anticipates double-digit revenue growth in 2025, driven by strategic initiatives and an expanding market presence.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.